EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Auto-immune hepatitis following COVID-19 Vaccination and SARS-COV2 infection : A narrative Review

M Bendoumou, P Langlet, T Gustot

Acta Gastro-Enterologica Belgica · 2026-06 · 89 (2) · 341-354

DOI: 10.51821/89.2.15138 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Gastro-Enterologica Belgica, 2026-06. Verfasst von M Bendoumou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Université Libre de Bruxelles, Belgium. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, COVID-19, COVID-19 Vaccines, Vaccination.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Since the onset of the COVID-19 pandemic, both SARS-CoV-2 infection and vaccination have been implicated as potential triggers for de novo autoimmune hepatitis (AIH). This review summarizes published cases, outlining clinical and biological features, treatment approaches, and outcomes.

Methods

A PubMed search identified reports of new-onset AIH following SARS-CoV-2 infection or COVID-19 vaccination up to February 1, 2025. Inclusion criteria encompassed case reports, series, and reviews. Data were extracted on demographics, vaccine type, onset timing, laboratory findings, histology, treatments, and outcomes.

Results

A total of 74 post-vaccination AIH cases and 22 post-infection cases were included. Post-vaccination AIH predominantly affected older women (median age 62) and occurred mainly after mRNA vaccines, with a median onset of 14 days. Most patients showed marked transaminase elevation, high IgG, and positive ANA (74.3%). Liver biopsies (performed in 92% of cases) showed features compatible with AIH. A total of 80% of the 50 cases of our study with available serology and liver histology were classified as probable / definite AIH, according to the simplified AIH score. Corticosteroid therapy was effective in most cases (survival 95.9%). Post-infection AIH cases showed similar features but affected younger individuals (median age 47), with uniformly favorable responses to immunosuppression.

Conclusions

New-onset AIH can occur following both SARS-CoV-2 infection or vaccination. Although these events remain rare, recognition of this association is essential for timely diagnosis and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis, AutoimmuneCOVID-19COVID-19 VaccinesVaccinationHumansFemaleSARS-CoV-2

Stichwörter der Autor:innen

autoimmune Hepatitiscoronavirus disease 2019vaccinevaccine-induced liver injury

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Université Libre de Bruxelles, Belgium.
  • Department of Gastroenterology, Centre Hospitalier Interrégional Edith Cavell, Brussels, Belgium.
  • Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Cliniques Universitaires de Bruxelles Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Zitieren

APA

Bendoumou, M., Langlet, P., & Gustot, T. (2026). Auto-immune hepatitis following COVID-19 Vaccination and SARS-COV2 infection : A narrative Review. Acta Gastro-Enterologica Belgica, 89(2), 341-354. https://doi.org/10.51821/89.2.15138

Vancouver

Bendoumou M, Langlet P, Gustot T. Auto-immune hepatitis following COVID-19 Vaccination and SARS-COV2 infection : A narrative Review. Acta Gastro-Enterologica Belgica. 2026;89(2):341-354. doi:10.51821/89.2.15138

BibTeX
@article{Bendoumou2026,
  author = {Bendoumou, M and Langlet, P and Gustot, T},
  title = {Auto-immune hepatitis following COVID-19 Vaccination and SARS-COV2 infection : A narrative Review},
  journal = {Acta Gastro-Enterologica Belgica},
  year = {2026},
  volume = {89},
  number = {2},
  pages = {341--354},
  doi = {10.51821/89.2.15138}
}
Kostenlos starten →